iShares Genomics Immunology and Healthcare ETF IDNA
At closeNov 3, 2026, 4:00 PM EST
After hours · Nov 3, 4:00 PM ET
- YTD
- +62.16%
- 1 year
- +70.36%
- Market cap
- 199.14M
- EPS (ttm)
- 1.56
- P/E ratio
- 27.29
- YTD return
- +62.16%
- 1-year return
- +70.36%
- Volume
- 119.14K
- Avg volume
- 145.50K
- Open
- 42.07
- Previous close
- 41.70
- Day's range
- 42.02 – 42.88
- 52-week range
- 24.29 – 43.79
2Y +17.85 (+72.68%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 24.11
- 200-day average
- 23.98
About iShares Genomics Immunology and Healthcare ETF
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on IDNA — it syncs with the Stock Master app.
